Sandoz to Stop Notifying CEs of 340B Contract Pharmacy Changes, Joins Liquidia in Adding Restrictions to New Drugs; Novartis Updates Restrictions

Sandoz announced in a June 4 notice to covered entities it “will no longer be providing additional notification for product changes to [its] contract pharmacy policy.”
Two drugmakers recently added new medications to the list of drugs subject to their respective 340B contract pharmacy restrictions—one of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug-Industry Funded Study Finds Utilization Drives 340B Program Growth, Not Rising Drug Prices

A recent drug-industry funded study in Health Affairs Scholar found that increased utilization, rather than rising drug prices, drives 340B program growth.
A recent drug-industry-funded study attributes the 340B program’s recent growth to increased utilization—not rising drug prices. The May 21 study, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In Emergency Motion, Novartis and BMS Urge Appellate Court to Fast-Track Their Appeals of 340B Rebate Ruling

Novartis and BMS filed an emergency motion with the federal appeals court in Washington, D.C. to appeal a recent ruling on drugmaker 340B rebates.
Novartis and Bristol Myers Squibb (BMS) are asking a federal appeals court to expedite their challenge to a recent ruling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Premier Asks Court to Reject HRSA’s Defense of 340B Hospital Drug Purchasing Restrictions Policy, Requests Oral Arguments

Premier again asked a Washington D.C. federal court to strike down a HRSA policy that restricts how certain 340B hospitals can purchase initial drug inventory.
A major group purchasing organization (GPO) recently urged a Washington D.C. federal court to reject the federal government’s defense of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

Keeping the Lifeline Strong: Why 340B Matters More Than Ever for Safety-Net Hospitals and Other Providers

SPONSORED CONTENT

Across America, safety-net hospitals stand as a lifeline for millions. These institutions serve patients who often have nowhere else to turn — individuals who are uninsured, underinsured, or living in communities where healthcare access is limited.

For hospitals operating on razor-thin margins, the 340B

Read More »

Hospital Group-Funded Working Paper Calls for Increased 340B Visibility Among Economists 

A recent working paper called for more economists to study the 340B program, which could broaden policymakers' understanding of its impact.
There’s a gap in economics research on the 340B program, and economists could enrich 340B stakeholders’ understanding of the program [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Amgen Exempts Tennessee Providers From 340B Contract Pharmacy Restrictions Despite New Law’s Carve Out

Amgen announced it will exempt Tennessee from its contract pharmacy restrictions, surprising some providers in the state due a grandfather clause in Tennessee's law.
Pharmaceutical giant Amgen recently announced it will exempt Tennessee providers from its contract pharmacy restrictions despite a carve out in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Indiana’s New Budget Law Sparks Alarm Over Last-Minute Provisions Targeting 340B Medicaid Reimbursement

Indiana's newly enacted budget law includes late-added provisions that could affect 340B providers serving Medicaid managed care beneficiaries.
A late amendment to Indiana’s newly enacted budget law grants the state broad authority to restrict how 340B drugs are [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Drugmakers File Briefs in 5th Circuit Appeals Case, Updates in Utah and Nebraska

Key briefs were filed in litigation on contract pharmacy access laws in Louisiana, Utah and Nebraska.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B INDUSTRY LEADER SPOTLIGHT

Holly Bones, Senior Director, 340B Manufacturer & Supply Chain Relations, Cencora

Holly Bones

Q: Where did you grow up?

Tamaqua, PA

Q: Where did you go to college?

Wilkes University, Wilkes-Barre, PA

Q: What are your favorites?

Food: Vanilla ice cream with rainbow sprinkles

Movie: Steel Magnolias

Musicians: Backstreet Boys, Breaking Benjamin, Taylor Swift

Destination: Las Vegas, Nevada

Q: What do you like to do outside

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live